SEGMENT REPORTING (Tables)

6 Months Ended

Jun. 30, 2025

Segment Reporting [Abstract]

SCHEDULE OF OPERATIONS, ASSETS AND CAPITAL EXPENDITURES FOR OUR BUSINESS SEGMENTS

The following table reflects results of operations including significant segment expenses that are regularly provided to the CODM for the Company’s reportable segments and Segment Adjusted EBITDA for the periods indicated below:

		Sanara Surgical				THP				Total				Sanara Surgical				THP				Total
		Three Months Ended June 30,
		2025												2024
		Sanara Surgical				THP				Total				Sanara Surgical				THP				Total
Net revenue		$	25,804,252			$	26,582			$	25,830,834			$	20,158,823			$	-			$	20,158,823
Cost of goods sold			1,937,282				-				1,937,282				2,008,686				-				2,008,686
Selling, general and administrative			19,634,319				1,918,875				21,553,194				18,349,924				607,684				18,957,608
Research and development			1,056,796				200,679				1,257,475				582,443				403,208				985,651
Depreciation and amortization			681,525				432,706				1,114,231				698,407				407,100				1,105,507
Change in fair value of earnout liabilities			-				-				-				89,330				(103,103	)			(13,773	)
Other expense ⁽¹⁾			1,987,050				-				1,987,050				644,346				-				644,346
Net income (loss)		$	507,280			$	(2,525,678	)		$	(2,018,398	)		$	(2,214,313	)		$	(1,314,889	)		$	(3,529,202	)
Segment Adjusted EBITDA		$	4,719,827			$	(2,054,987	)		$	2,664,840			$	1,393,959			$	(801,778	)		$	592,181

		Sanara Surgical				THP				Total				Sanara Surgical				THP				Total
		Six Months Ended June 30,
		2025												2024
		Sanara Surgical				THP				Total				Sanara Surgical				THP				Total
Net revenue		$	49,238,348			$	26,582			$	49,264,930			$	38,695,461			$	-			$	38,695,461
Cost of goods sold			3,772,249				-				3,772,249				3,898,732				-				3,898,732
Selling, general and administrative ⁽²⁾			38,763,527				4,230,277				42,993,804				34,032,964				1,116,903				35,149,867
Research and development			2,007,155				364,458				2,371,613				1,161,424				770,525				1,931,949
Depreciation and amortization			1,370,096				868,545				2,238,641				1,396,908				814,019				2,210,927
Change in fair value of earnout liabilities			-				-				-				(14,451	)			(65,000	)			(79,451	)
Other expense ⁽¹⁾			3,433,146				1,258				3,434,404				911,682				-				911,682
Net loss		$	(107,825	)		$	(5,437,956	)		$	(5,545,781	)		$	(2,691,798	)		$	(2,636,447	)		$	(5,328,245	)
Segment Adjusted EBITDA		$	7,414,885			$	(4,092,077	)		$	3,322,808			$	2,532,145			$	(1,628,543	)		$	903,602

	(1)	For the three months ended June 30, 2025, other expense included interest expense and share of losses from equity method investments. For the three months ended June 30, 2024, other expense included interest expense. For the six months ended June 30, 2025, other expense included interest expense and share of losses from equity method investments, offset by interest income and gain on disposal of property and equipment. For the six months ended June 30, 2024, other expense included interest expense.

	(2)	For the six months ended June 30, 2024, $90,293 of selling, general and administrative expenses were reclassified from the Sanara Surgical segment to the THP segment.

SCHEDULE OF RECONCILIATION OF NET INCOME (LOSS) TO SEGMENT EBITDA FOR REPORTABLE SEGMENTS

The following table provides a reconciliation of net income (loss) to Segment Adjusted EBITDA for the Company’s reportable segments for the periods indicated below:

		Sanara Surgical				THP ⁽³⁾				Total				Sanara Surgical				THP				Total
		Three Months Ended June 30,
		2025												2024
		Sanara Surgical				THP⁽³⁾				Total				Sanara Surgical				THP				Total
Net Income (Loss)		$	507,280			$	(2,525,678	)		$	(2,018,398	)		$	(2,214,313	)		$	(1,314,889	)		$	(3,529,202	)
Adjustments:
Interest expense			1,791,568				-				1,791,568				644,346				-				644,346
Depreciation and amortization			681,525				432,706				1,114,231				698,407				407,100				1,105,507
Noncash share-based compensation			1,278,871				26,394				1,305,265				1,046,321				36,429				1,082,750
Change in fair value of earnout liabilities			-				-				-				89,330				(103,103	)			(13,773	)
Share of losses from equity method investments			195,482				-				195,482				-				-				-
Executive separation costs ⁽¹⁾			260,275				-				260,275				904,780				-				904,780
Acquisition costs ⁽²⁾			4,826				11,591				16,417				225,088				172,685				397,773
Segment Adjusted EBITDA		$	4,719,827			$	(2,054,987	)		$	2,664,840			$	1,393,959			$	(801,778	)		$	592,181

		Sanara				THP ⁽³⁾				Total				Sanara				THP				Total
		Six Months Ended June 30,
		2025												2024
		Sanara Surgical				THP⁽³⁾				Total				Sanara Surgical				THP				Total
Net Loss		$	(107,825	)		$	(5,437,956	)		$	(5,545,781	)		$	(2,691,798	)		$	(2,636,447	)		$	(5,328,245	)
Adjustments:
Interest expense			3,108,660				-				3,108,660				911,682				—				911,682
Depreciation and amortization			1,370,096				868,545				2,238,641				1,396,908				814,019				2,210,927
Noncash share-based compensation			2,454,367				155,802				2,610,169				1,799,936				86,200				1,886,136
Change in fair value of earnout liabilities			-				-				-				(14,451	)			(65,000	)			(79,451	)
Share of losses from equity method investments			339,090				-				339,090				-				-				-
(Gain) loss on disposal of property and equipment			(10,932	)			1,258				(9,674	)			-				-				-
Interest income			(3,672	)			-				(3,672	)			-				-				-
Executive separation costs ⁽¹⁾			260,275				-				260,275				904,780				-				904,780
Acquisition costs ⁽²⁾			4,826				320,274				325,100				225,088				172,685				397,773
Segment Adjusted EBITDA		$	7,414,885			$	(4,092,077	)		$	3,322,808			$	2,532,145			$	(1,628,543	)		$	903,602

	(1)	Includes $130,174 and $328,795 of share-based compensation related to executive separation costs for the three and six months ended June 30, 2025 and 2024, respectively.

	(2)	Acquisition costs include legal, tax, accounting and other contract services related to prospective acquisitions.

	(3)	The THP segment does not include $1.7 million and $3.4 million of internal use software costs capitalized during the three and six months ended June 30, 2025, respectively.